KEI Comments to NIH on Exclusive License to TeraImmune for T-cell Therapy for Multiple Sclerosis
(Update: The NIH provided a response to our questions and comments on February 28, 2022) On February 9, 2022, Knowledge Ecology International (KEI) filed comments with the National Institutes of Health regarding the “Prospective Grant of Exclusive Patent License: Development… Continue Reading